Product Information
DROSPIRENONE-EE 3-0.03 MG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1511 per EA under NDC 68462073329. Its NADAC has been published 534 times since Jul 13, 2016.
FDA first approved this application on Mar 25, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462073329
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA204848FDA Approved
3/25/2016
TE Code
AB
On Market Since
3/25/2016
Price Statistics
The NADAC for DROSPIRENONE-EE 3-0.03 MG TAB has been published 534 times since Jul 13, 2016, and over the history we have for it it has declined 89.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1511 per EA |
|---|---|
| All-time high | $1.4686 (Sep 14, 2016) |
| All-time low | $0.1445 (Jul 22, 2026) |
| 52-week high | $0.1731 |
| 52-week low | $0.1445 |
| Median price | $0.3031 |
| Average price | $0.3843 |
| Largest weekly change | +27.6% (Jun 19, 2024) |
| Weeks tracked | 534 |
| Tracking since | Jul 13, 2016 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
drospirenone and ethinyl estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DROSPIRENONE-EE 3-0.03 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DROSPIRENONE-EE 3-0.03 MG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1511 per EA (NDC 68462073329), effective Sep 30, 2026.
How has the price of DROSPIRENONE-EE 3-0.03 MG TAB changed over time?
Over the history we have for it, the NADAC for DROSPIRENONE-EE 3-0.03 MG TAB has declined 89.0%. It has been tracked across 534 weekly CMS publications since Jul 13, 2016.
What are the highest and lowest recorded NADAC prices for DROSPIRENONE-EE 3-0.03 MG TAB?
Since Jul 13, 2016, the NADAC for DROSPIRENONE-EE 3-0.03 MG TAB has ranged from a low of $0.1445 (Jul 22, 2026) to a high of $1.4686 (Sep 14, 2016), with a median of $0.3031 per EA.
Are there cheaper alternatives to DROSPIRENONE-EE 3-0.03 MG TAB?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DROSPIRENONE-EE 3-0.03 MG TAB, is $0.1492 per EA — about 1% below DROSPIRENONE-EE 3-0.03 MG TAB.
Who manufactures DROSPIRENONE-EE 3-0.03 MG TAB?
DROSPIRENONE-EE 3-0.03 MG TAB (NDC 68462073329) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.